Abstract
Background
Current mammalian models for heart regeneration research are limited to neonatal apex amputation and myocardial infarction, both of which are controversial. RNAseq has demonstrated a very limited set of differentially expressed genes between sham and operated hearts in myocardial infarction models. Here, we investigated in rats whether pressure overload in the right ventricle, a common phenomenon in children with congenital heart disease, could be used as a better animal model for heart regeneration studies when considering cardiomyocyte proliferation as the most important index.
Methods and Results
In the rat model, pressure overload was induced by pulmonary artery banding on postnatal day 1 and confirmed by echocardiography and hemodynamic measurements at postnatal day 7. RNA sequencing analyses of purified right ventricular cardiomyocytes at postnatal day 7 from pulmonary artery banding and sham‐operated rats revealed that there were 5469 differentially expressed genes between these 2 groups. Gene ontology and Kyoto Encyclopedia of Genes and Genomes analysis showed that these genes mainly mediated mitosis and cell division. Cell proliferation assays indicated a continuous overproliferation of cardiomyocytes in the right ventricle after pulmonary artery banding, in particular for the first 3 postnatal days. We also validated the model using samples from overloaded right ventricles of human patients. There was an approximately 2‐fold increase of Ki67/pHH3/aurora B‐positive cardiomyocytes in human‐overloaded right ventricles compared with nonoverloaded right ventricles. Other features of this animal model included cardiomyocyte hypotrophy with no fibrosis.
Conclusions
Pressure overload profoundly promotes cardiomyocyte proliferation in the neonatal stage in both rats and human beings. This activates a regeneration‐specific gene program and may offer an alternative animal model for heart regeneration research.
Keywords: cardiomyocyte, pressure overload, proliferation, right ventricle, RNA‐seq
Subject Categories: Basic Science Research, Myocardial Regeneration, Heart Failure, Congenital Heart Disease
Nonstandard Abbreviations and Acronyms
- GO
gene ontology
- HF
heart failure
- KEGG
Kyoto Encyclopedia of Genes and Genomes
- PA
pulmonary artery
- PAB
pulmonary artery banding
- pHH3
phospho‐histone H3
- RNA‐seq
RNA sequencing
- RVCM
right ventricular cardiomyocyte
- RV
right ventricle
Clinical Perspective
What Is New?
Pressure overload, activating a regeneration‐specific gene program, profoundly promotes cardiomyocyte proliferation in the neonatal stage in both rats and human beings.
What Are the Clinical Implications?
When considering cardiomyocyte proliferation as the most important index, the pressure overload model could be a better animal model for heart regeneration studies than neonatal apex amputation and myocardial infarction models.
Heart failure (HF) is a leading cause of death, and an estimated 26 million people have HF worldwide.1 HF ranks as the highest healthcare expense in China.2 Stimulating pre‐existing cardiomyocytes to proliferate and replace unhealthy or damaged cardiomyocytes after myocardial infarction or other trauma is a fundamental part of treating HF.3 However, current mammalian models for heart regeneration research are limited to neonatal apex amputation and myocardial infarction, both of which are rarely observed in human infants, so it is difficult to find matched human infant samples to study regeneration. There are many inconsistent reports on these 2 models when considering regeneration: some authors have reported there is regeneration, while others have reported there is not regeneration.4, 5, 6, 7, 8, 9, 10 Moreover, RNA sequencing (RNA‐seq) transcriptome analysis has demonstrated only a very limited differential expression of genes between neonatal heart tissue with myocardial infarction and sham‐operated heart tissue,11 bringing into question whether a myocardial infarction model is really suitable for the study of heart regeneration.7, 10
Pressure load is a key factor during fetal heart development. Without pressure load, the growth of the myocardium and heart size will be diminished.12 During the neonatal stage, pressure overload also increases left ventricular cardiomyocyte proliferation, which protects the heart from maladaptation.13 However, in clinical practice, pressure overload in the right ventricle (RV) is more common than in the left ventricle in children with congenital heart disease, such as tetralogy of Fallot, pulmonary artery hypertension, and pulmonary stenosis.14, 15, 16 Whether pressure overload promotes right ventricular cardiomyocyte proliferation is unknown. If pressure overload contributes to both left and right ventricular cardiomyocyte proliferation at the neonatal stage, it is possible that it may contribute to prenatal cardiomyocyte proliferation. Pressure load to ventricle tissue at the late prenatal stage may be applied to rescue the tissue from dysplasia. Minimally invasive fetal surgery, which is increasingly common for lung and other diseases,17 may also serve to rescue ventricular tissue from dysplasia, which otherwise generally requires heart transplantation after birth.18
An important issue is the differences between the left ventricles and RVs. The RV is different from the left ventricle in its anatomic, electrical, and cellular configuration.19 More importantly, the pressures are different, which may impact the stiffness needed to handle wall pressure.19 The RV often fails because of distinct pathobiological pathways that are separate from those of the left ventricle and therapy that influences the left ventricle favorably may not impact a dysfunctional RV.20 Therefore, understanding whether pressure overload contributes to RV cardiomyocyte proliferation may be of benefit to the treatment of right ventricular failure.
Based on our previously described original right ventricular pressure overloaded rat model,21 we performed RNA‐seq to find out whether and how pressure overload can contribute to right ventricular cardiomyocyte proliferation. Also based on our previous publication and on the work of Polizzotti et al showing that human cardiomyocytes have a therapeutic/proliferation window,22, 23 we selected pressure overload of a human heart sample, age <3 months old, to verify the RNA‐seq results.
Materials and Methods
Data generated in this study are available from the corresponding author upon reasonable request. All of the RNA‐seq data has been deposited in the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE139561.
All primers, reagents, and antibodies information are provided in Tables S1 through S3.
Animal Experiments
Pregnant Sprague–Dawley rats were purchased from Xipu'er‐bikai Experimental Animal Co., Ltd (Shanghai, China). After birth, the rat neonates (both males and females) were randomized into 2 groups: an experimental group (PAB group), and a control group (sham group) that underwent the same procedure except for the banding step. Pulmonary artery banding (PAB) surgery was performed according to our previous publication.21 Briefly, after neonatal rats were anesthetized by ice cooling, they were transferred to an ice bed and fixed in the supine position. Horizontal thoracotomy was performed to reveal the pulmonary artery (PA). An 11‐0 nylon thread was positioned under the PA, and a 30‐gauge needle (0.31‐mm diameter) was placed on the PA. The PA and needle were then tied together by the thread. We then removed the needle to form a fixed, constricted opening in the PA lumen. We closed the thoracic wall and then warmed the neonatal rats with a heat plate until natural movements and a red/pink complexion were achieved. We have provided a surgical video of our right ventricular overload model on a website 21 to enable others to learn the technique. All of the procedures conformed to the principles outlined in the Declaration of Helsinki and were approved by the Animal Welfare and Human Studies Committee at Shanghai Children's Medical Center.
Transthoracic Echocardiography
Rats were anesthetized with isoflurane and allowed to breathe spontaneously through a nasal cone (isoflurane/oxygen: 1.5%–2.0% maintenance). Echocardiograms were analyzed with a Vevo 2100 imaging system (Visual Sonics, Toronto, Ontario, Canada), and a long‐axis view of the PA was used to measure the peak pressure gradient across the PA constriction by continuous‐wave Doppler.
Histology
Postnatal day 7 (P7) rat hearts were fixed in 4% paraformaldehyde overnight at 4°C, then dehydrated in an ethanol series, embedded in paraffin, and sectioned into 6‐μm slices. Hematoxylin and eosin staining was performed.
Cardiomyocyte Isolation and Purification
At P7, the young rats were decapitated. The hearts were carefully taken from the chest, and cardiomyocytes were dissociated by Langendorff reverse coronary perfusion with 200 μg/mL Liberase DH (Roche), as described elsewhere.9 Cardiomyocytes were enriched by differential adherence and low‐speed centrifugation.24 The purity of cardiomyocytes was confirmed by flow cytometry. The purified cardiomyocytes were used for total RNA preparation and RNA‐seq.
Total RNA Preparation and Real‐Time Quantitative PCR Analysis
For mRNA quantification, mRNA was extracted and purified using a PureLink RNA Micro Scale Kit (Catalog No. 12183016; Life Technologies, Carlsbad, CA). RT‐PCR was performed using the PrimeScript™ reagent kit (Takara Bio, Kusatsu, Japan). Quantitative real‐time polymerase chain reaction (qRT‐PCR) were carried out using SYBR Green Power Premix Kits (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. qRT‐PCR was performed with a 7900 Fast Real‐Time PCR System (Applied Biosystems), and the following conditions were used: 1 cycle at 95°C for 10 s, followed by 40 cycles of 95°C for 15 s and 60°C for 60 s. The primers were obtained from Generay Biotech Co., Ltd (Shanghai, China). The relative fold change was then calculated using the ΔΔCT method.
Library Preparation for Transcriptome Sequencing
A total amount of 1 μg RNA per sample was used as input material for the RNA sample preparations. Sequencing libraries were generated using the NEBNext® Ultra™ RNA Library Prep Kit for Illumina® (NEB, USA) following the manufacturer's recommendations. Index codes were added to attribute sequences to each sample. Briefly, mRNA was purified from total RNA using poly‐T oligo‐attached magnetic beads. Fragmentation was carried out using divalent cations under elevated temperature in NEB Next First Strand Synthesis Reaction Buffer (5×). First strand cDNA was synthesized using random hexamer primers and M‐MuLV Reverse Transcriptase (RNase H –). Second strand cDNA synthesis was subsequently performed using DNA polymerase I and RNase H. Remaining overhangs were converted into blunt ends via exonuclease/polymerase activities. After adenylation of the 3′ ends of the DNA fragments, NEBNext Adaptors with hairpin loop structures were ligated to prepare for hybridization. In order to select cDNA fragments of preferentially 250–300 bp in length, the library fragments were purified with the AMPure XP system (Beckman Coulter, Beverly, MA). Then 3 μL USER Enzyme (NEB, USA) was used with size‐selected, adaptor‐ligated cDNA at 37°C for 15 minutes followed by 5 minutes at 95°C. Then, PCR was performed with Phusion High‐Fidelity DNA polymerase, Universal PCR primers, and Index (X) Primer. At last, PCR products were purified (AMPure XP system), and library quality was assessed on an Agilent Bioanalyzer 2100 system.
Clustering and Sequencing
The clustering of the index‐coded samples was performed on a cBot Cluster Generation System using a TruSeq PE Cluster Kit v3‐cBot‐HS (Illumina) according to the manufacturer's instructions. After cluster generation, the library preparations were sequenced on an Illumina Novaseq platform, and 150 bp paired‐end reads were generated.
Quality Control, Read Mapping, and Quantification of Gene Expression Levels
Raw data (raw reads) in fastq format were first processed through in‐house Perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapters, reads containing poly‐N, and low‐quality reads from raw data. At the same time, Q20, Q30, and GC content of the clean data were calculated. All of the downstream analyses were based on the clean data with high quality.
Reference genome and gene model annotation files were downloaded from the genome website directly. The index of the reference genome was built using Hisat2 v2.0.5, and paired‐end clean reads were also aligned to the reference genome using Hisat2 v2.0.5. We selected Hisat2 as the mapping tool since it can generate a database of splice junctions based on the gene model annotation file and thus a better mapping result than other nonsplice mapping tools.
The expected number of fragments per kilobase of transcript sequence per million base pairs sequenced considers the effect of sequencing depth and gene length for the reads counted at the same time. Fragments per kilobase of transcript sequence per million is currently the most commonly used method for estimating gene expression levels. For this, featureCounts v1.5.0‐p3 was used to count the number of reads mapped to each gene. Then, fragments per kilobase of transcript sequence per million of each gene was calculated based on the length of the gene and read counts mapped to each gene.
Differential Expression Analysis and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes Enrichment Analysis of Differentially Expressed Genes
Differential expression analysis was performed using the DESeq2 R package (1.16.1). DESeq2 provides statistical routines for determining differential expression in digital gene expression data using a model based on the negative binomial distribution. The resulting P values were adjusted using Benjamini and Hochberg's approach for controlling the false discovery rate. Genes with an adjusted P value of <0.05 found by DESeq2 were assigned as differentially expressed.
Gene Ontology (GO) enrichment analysis of differentially expressed genes was implemented by the clusterProfiler R package, in which gene length bias was corrected. GO terms with corrected P values <0.05 considered to be significantly enriched by differentially expressed genes.
Kyoto Encyclopedia of Genes and Genomes (KEGG) is a database resource for understanding high‐level functions and utilities of biological systems, such as the cell, the organism, and the ecosystem, from molecular‐level information, especially large‐scale molecular data sets generated by genome sequencing and other high‐throughput experimental technologies (http://www.genome.jp/kegg/). We used the clusterProfiler R package to test the statistical enrichment of differentially expressed genes in KEGG pathways.
Tetralogy of Fallot Patients
We collected 20 right‐ventricular‐outflow myocardial tissue specimens from resections required to relieve obstructions in tetralogy of Fallot (TOF) patients at the Shanghai Children's Medical Center, Shanghai, China, between February 2015 and July 2018. Each specimen was preserved in liquid nitrogen and later divided into 3 portions, which were used for DNA extraction, qRT‐PCR, and immunofluorescence. All of the procedures conformed to the principles outlined in the Declaration of Helsinki and were approved by the Animal Welfare and Human Studies Committee at the Shanghai Children's Medical Center. Parental written informed consent was obtained before study initiation.
Immunofluorescence
Slides were washed 3 times with PBS, fixed with 4% paraformaldehyde for 10 minutes, permeated with 0.5% Triton X‐100 for 15 minutes, blocked with 10% donkey serum for 30 minutes, and stained with primary antibodies overnight at 4°C. After washing the slides 3 more times, we incubated the sections or cells with secondary antibodies and 4′,6‐diamidino‐2‐phenylindole for 30 minutes. Three researchers who were blinded to sample identity quantified cellular Ki67, phospho‐histone H3 (pH3), and aurora B via either manual counting or digital thresholding. This included image segmentation and creation of a binary image from a grayscale. We analyzed the converted binary images using ImageJ software (NIH, Bethesda, MD; Laboratory for Optical and Computational Instrumentation, University of Wisconsin, Madison, WI).
EdU Labeling
For EdU labeling experiments, rats were injected subcutaneously with 5 μg/g EdU at 24 hours before harvesting and signals were detected with a Click‐iT@ Imaging Kit according to the manufacturer's instructions.
Statistical Analysis
Continuous data, including mRNA expression, protein expression, and number of Ki67/pH3/aurora B‐positive cells, were expressed as means±SD. Differences were tested with Student t test if the data were normally distributed, otherwise they were tested with the rank sum test. P values <0.05 were considered to be statistically significant. Statistical analyses were performed using SAS software version 9.2 (SAS Institute Inc., Cary, NC).
Results
Right Ventricular Pressure Load Is Significantly Increased in PAB Rats
To investigate whether pressure overload affects the proliferation of neonatal RV cardiomyocytes, first we constructed a RV pressure overload model by PAB in postnatal day 1(P1) rats. Most of the animals died in the first 2 days after surgery from P1 to P28. We thought the death may have been related to surgery. The survival rate was >75% on P28. After P28, most of them showed severe symptoms of right HF, such as cyanosis, ascites, and increased breathing rate, and they also began dying. We observed the rats up to 6 months, with one third left, which were euthanized. The autopsy showed the thrombosis in the femoral vein and significant right ventricular hypertrophy. Relative to the sham group, the peak pressure gradients across the PA constriction were significantly increased in the PAB group on P7 (Figure 1A and 1B). Consistently, histological examination showed that the RV free wall was significantly hypertrophic in the PAB group (n=6, P=0.0017, Figure 1C through E).Because of the increase of RV pressure, the septum moved toward the left ventricle (Figure 1C) These results suggested that RV pressure overload was successfully constructed as we previous showed.21
Pressure Overload Greatly Changes Genes Expression in Neonatal Right Ventricular Cardiomyocytes
To investigate how pressure overload changes gene expression in right ventricular cardiomyocytes (RVCMs), we isolated and purified cardiomyocytes from the RVs of the hearts of PAB and sham‐operated mice (Figure S1) and performed RNA‐seq on these cardiomyocytes. We verified the RNA‐seq results by qRT‐PCR (Figures S2 and S3) and have provided the list of top 24 genes and their detailed information (Figure S2 and Table S4). Our results showed that there were 5469 differentially expressed genes, among which 2567 were downregulated and 2902 were upregulated (Figure 2A). These 2 groups of cardiomyocytes shared 13 257 expressed genes in common. In the PAB group, another 624 genes were expressed (operation1week, opt1w), and 695 genes were expressed only in the sham group (control1week, con1w) (Figure 2B). When these genes were clustered, a heatmap showed that the individual rats in the same group were similar to each other but were noticeably different from the rats in the other group (Figure 2C).
Most Enriched GO Terms Are Closely Related to Cell Proliferation
We performed GO analysis to find out whether the differentially expressed genes were associated with cell proliferation. Biological process analysis showed that the top 10 most enriched GO terms were chromosome segregation, sister chromatid segregation, mitotic sister chromatid segregation, nuclear chromosome segregation, DNA replication, DNA repair, DNA‐dependent DNA replication, regulation of cell cycle process, mitotic nuclear division, and organelle fission (Figure 3A through C). Cell component analysis showed the top 10 most enriched GO terms were chromosomal region, kinetochore, condensed chromosome‐centromeric region, condensed chromosome kinetochore, condensed chromosome, spindle, centrosome, condensed chromosome outer kinetochore, and condensed nuclear chromosome kinetochore (Figure 3A through D). Molecular function analysis showed the top 10 most enriched GO terms were DNA‐dependent ATPase activity, catalytic activity acting on DNA, histone binding, ATP‐dependent DNA helicase activity, modification‐dependent protein binding, damaged DNA binding, helicase activity, ATP‐dependent 3′‐5′ DNA helicase activity, and single‐stranded DNA binding (Figure 3A, 3B, and 3E). GO analysis suggested that pressure overload significantly promoted cardiomyocyte proliferation.
KEGG Pathway Analysis Showed That Most Enriched Terms Were Closely Related to Cell Proliferation
We performed KEGG pathway analysis to find out whether the pathways regulating differentially expressed genes were associated with cell proliferation. The top 10 enriched pathways were cell cycle, DNA replication, nucleotide excision repair, mismatch repair, small cell lung cancer, pyrimidine metabolism, homologous recombination, base excision repair, bladder cancer, and Fanconi anemia pathway (Figure 4A through C). KEGG pathway analysis suggested that pressure overload largely activated pathways associated with cell proliferation.
Verification of RNA‐seq Results by Proliferation Marker Detection
To confirm the RNA‐seq results, we performed immunostaining on both PAB rat model samples at P7 and on human samples of pressure‐overloaded RVs (Table). The number of Ki67‐positive cardiomyocytes per section was 262.9±15.1 in the PAB group and 182.1±14.4 in the sham group (Figure 5A and 5B). The number of pH3‐positive cardiomyocytes was 66.4±5.9 in the PAB group and 45.3±4.9 in the sham group (Figure 5C and 5D). The percentage of pH3‐positive cardiomyocytes in sham and PAB groups was 0.412%±0.162% and 1.585%±0.223%, respectively (P<0.0001, n=10), and the percentage of Ki67‐positive cardiomyocytes in sham and PAB was 2.563%±0.381% and 7.628%±1.468%, respectively (P<0.0001, n=10) (Figure S4). The number of aurora B‐positive cardiomyocytes was 3.8±0.9 in the PAB group and 0.4±0.5 in the sham group (Figure 5E and 5F). In addition to immune staining, we also used synthetic nucleoside uptake to confirm the above results. As shown in Figure S5, at P7 the number of EdU‐positive cardiomyocytes per section was 555.9±64.6 in the PAB group and 286±53.8 in the sham group.
Table 1.
Group | Sampling Date | Age (mo) | Sex | Body Weight (kg) | Right Ventricle Pressure Load (mm Hg) | SaO2 (%) |
---|---|---|---|---|---|---|
Nonoverload | 2015/3/20 | 2.2 | Male | 4.5 | 10.96 | 89 |
2015/6/23 | 3 | Male | 6 | 20.6 | 98 | |
2015/8/24 | 2.3 | Female | 5.4 | 28.5 | 63 | |
2016/3/29 | 3 | Male | 6.2 | 21.4 | 69 | |
2016/5/25 | 2.5 | Female | 7.5 | 18.6 | 89 | |
2016/7/8 | 2.3 | Female | 8 | 17.7 | 87 | |
2017/11/30 | 2.4 | Female | 7.3 | 27.5 | 73 | |
2018/4/3 | 3 | Male | 5.7 | 16.7 | 98 | |
2018/4/17 | 3 | Male | 7 | 26.8 | 77 | |
2018/7/6 | 3 | Male | 6.2 | 26.4 | 78 | |
Pressure overload | 2015/3/6 | 3 | Male | 4.8 | 70 | 80 |
2015/4/7 | 2.5 | Male | 6 | 114 | 88 | |
2015/9/8 | 3 | Male | 6.1 | 64 | 88 | |
2016/1/14 | 2.8 | Female | 7.3 | 96 | 80 | |
2016/3/11 | 2.1 | Male | 6.6 | 70.9 | 80 | |
2016/4/12 | 3 | Male | 5.8 | 73 | 88 | |
2017/5/18 | 2.9 | Male | 6.5 | 65 | 87 | |
2017/6/16 | 3 | Male | 5 | 186.1 | 85 | |
2018/3/19 | 3 | Male | 7.1 | 64 | 87 | |
2018/5/21 | 3 | Male | 7.5 | 88 | 86 |
SaO2 indicates arterial oxygen percent saturation.
In the human RV samples, the number of Ki67‐positive cardiomyocytes per section in the non‐overload group was 14.6±3.5 and in the overload group it was 30±3.2 (P<0.0001, Figure 5G and 5I). The number of pH3‐positive cardiomyocytes per section in the nonoverload group was 4.3±1.4 and in the overload group it was 10.5±2.1 (P<0.0001, Figure 5H and 5I). The number of aurora B‐positive cardiomyocytes was 1.5±0.5 in the overloaded group while there were none observed in the nonoverload group (Figure 5J and 5K). RNA‐seq data (GSE139561) showed that the average fragments per kilobase of transcript sequence per million of AURKB in the PAB group was 9.54±1.07 and in the sham group it was 4.21±0.42. qRT‐PCR results showed that the relative mRNA level of AURKB increased ≈10‐fold (Figure S2).
These results suggested that pressure overload indeed profoundly promoted and extended the rate of the proliferation of RVCMs both in humans and rats.
Effect of Pressure Overload on RVCM Proliferation Diminishes With Age
Another important issue is the age‐associated proliferation ability of cardiomyocytes.11, 23 We examined the proliferation status of cardiomyocytes at P3 and P14. We found that the number of Ki67‐positive RVCMs in the sham group at P3, P7, and P14 was 205.6±20.6, 182.1±14.4, and 26.8±2.7, respectively, and the number of pH3‐positive RVCMs in the sham group at P3, P7, and P14 was 54±6.3, 45.3±4.9, and 13.6±1.7, respectively (Figure 6A through C). When these RVCMs were subjected to pressure overload, we found that the Ki67‐fold change (relative to the sham group) at P3, P7, and P14 was 2.4±0.2, 1.5±0.2, and 1.1±0.2, respectively, and the pH3‐fold change at P3, P7, and P14 was 2.3±0.6, 1.5±0.2, and 1.0±0.2, respectively (Figure 6A through C). EdU uptake experiments showed that the number of EdU‐positive RVCMs in the sham group at P3, P7, and P14 was 498.5±63.1, 286±53.8, and 193.7±30.4, respectively, and in the PAB group at P3, P7, and P14 were 826±72.8, 555.9±64.6, and 251.6±30.4, respectively (Figure S5). These data demonstrate that the effects of pressure overload on the promotion of RVCM proliferation diminish with age.
Cardiomyocyte Hypertrophy Without RV Fibrosis in the Pressure Overload Model
At the adult stage, pressure overload induces RVCMs hypertrophy, but how pressure overload affects neonatal RVCMs is largely unknown. We found that cell size increased 42% (Figure 7A and 7B), and cardiac hypertrophy markers atrial natriuretic peptide and brain natriuretic peptide increased 33.3‐fold and 16.5‐fold, respectively (Figure 7C).
Fibrosis is an important feature of both the apex resection model and the myocardial infarction model. Therefore, we investigated fibrosis in the pressure overload model. Fibrosis was undetectable (Figure 7D) in the pressure overload model. The expression levels of markers such as collagen type I alpha 1, collagen type III alpha 1, and type II and type IV collagen had no change between the PAB and sham groups at P7 (Figure 7E through G).
These results suggest that cardiomyocyte hypertrophy, but not fibrosis, is a feature of the pressure overload model.
Discussion
A good disease model is critical for disease research. Current animal models for heart regeneration studies are controversial. Since 2011, when Porrello et al reported a 7‐day transient regenerative potential of the neonatal mouse heart,25 heart regeneration results have always been challenged. Andersen et al followed an apex resection model for 180 days and found persistent scarring and dilated cardiomyopathy,7 suggesting there was no regeneration. Bryant et al performed a systematic analysis of an apical resection model and found that the sizes of the cardiac resection and the surgical retraction of the ventricular apex both played critical roles in the resection model.10 Even more recently, Notari et al reported that only 1‐day‐old neonatal mice had regenerative potential, but that 2‐day‐old mice responded to amputation with fibrosis rather than regeneration.26 When considering a myocardial infarction model, Haubner et al reported that there was only a very limited set of differentially expressed genes between sham operation and myocardial infarction heart tissue.11 Quaife‐Ryan et al did multicellular transcriptional analysis on the regenerative heart and found that the majority of transcriptional changes in all of the cardiac cell types resulted from developmental maturation from neonatal stages to adulthood rather than activation of a distinct regeneration‐specific gene program.9 The above findings question the suitability of apex resection and myocardial infarction models for heart regeneration studies. The adult myocardial infarction model is used for the understanding the pathophysiological processes of adult myocardial infarction patients. Here, we present a new model of heart regeneration. Our RNA‐seq data showed that there were >5000 genes that were differentially expressed. GO and KEGG pathway analysis suggested that most of these differentially expressed genes were involved in mitosis and cell division. These results suggest that, compared with apex resection models and myocardial infarction models, the pressure overload model is much better.
Another interesting feature of the pressure overload model is that pressure overload extends the time frame of cardiomyocyte proliferation. Usually at P7, cardiomyocyte gene programs change from proliferation to maturation and hypertrophy. Our results showed that at P7 there were still many proliferating genes that were active. However, it should be noted that the proliferative activity of RVCMs diminished with time, and hypertrophy was inevitable. This suggested that PAH (pulmonary artery hypertension) cannot change the exit of cell cycle of RVCM. It is better to perform the PAB model to study heart regeneration before P7.
An exciting result revealed by Malek et al showed that pressure overload induces left ventricular cardiomyocyte proliferation.13 However, that study did not compare sham and operated cardiomyocytes by RNA‐seq at P7, so we do not know what transcriptomic changes existed between their sham and operated cardiomyocytes. Combined with their study, we conclude that pressure overload is able to induce the whole heart to proliferate at the neonatal stage. This may mean that we are able to induce cardiomyocyte proliferation at the prenatal stage by pressure overload, since minimally invasive prenatal surgery is becoming more common.17
In clinical practice, many congenital heart diseases, such as pulmonary stenosis, tetralogy of Fallot, double‐outlet RV, transposition of the great arteries, and others, have RV overload right after birth. Little is known about how the neonatal RV responds to pressure and/or volume overload. Previous studies have applied monocrotaline or chronic hypoxia to induce pulmonary hypertension that increases RV afterload.27, 28 Those methods take at least 1 week to establish pulmonary hypertension. Hence, they are unlikely to be useful for studying RV remodeling right after birth. Here, we established a neonatal RV overload rat model by constricting the main pulmonary artery at P1. With this system, we can model the pathogenesis of many congenital heart diseases. Since there are many children with congenital heart disease with RV or left ventricle overload, this will make it easier to test the results of the pressure overload model on human beings than would the apex resection model or myocardial infarction model.
In summary, we present a new model for heart regeneration studies. If we take cardiomyocyte proliferation as the main index, this model is much better than the controversial apex resection and myocardial infarction models. In clinical practice, there are many children with congenital heart disease with pressure overload, which makes our model more attractive for medical translational purposes.
Sources of Funding
This work was supported by the National Natural Science Foundation of China (Nos. 81670287 and 81800285), National Key R&D Program of China (No. 2019YFA0110401), Foundation of Pudong Science and Technology Development (No. PKJ2016‐Y35 and PKJ2019‐Y12), Foundation of Shanghai Health and Family Planning Committee (No. 20164Y0106), Program for Outstanding Medical Academic Leader in Shanghai (Hao Zhang), and National Basic Research Program of China (No. 2013CB945304).
Disclosures
None.
Supporting information
(J Am Heart Assoc. 2020;9:e015574 DOI: 10.1161/JAHA.119.015574.)
For Sources of Funding and Disclosures, see page 13.
Contributor Information
Zhuoming Xu, Email: zmxyfb@163.com.
Haifa Hong, Email: hhfsmallboat@163.com.
References
- 1. Shudo Y, Wang H, Lingala B, He H, Kim FY, Hiesinger W, Lee AM, Boyd JH, Currie M, Woo YJ. Evaluation of risk factors for heart‐lung transplant recipient outcome: an analysis of the united network for organ sharing database. Circulation. 2019;140:1261–1272. [DOI] [PubMed] [Google Scholar]
- 2. Zhang Y, Zhang J, Butler J, Yang X, Xie P, Guo D, Wei T, Yu J, Wu Z, Gao Y, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China‐HF) Registry. J Card Fail. 2017;23:868–875. [DOI] [PubMed] [Google Scholar]
- 3. Schüttler D, Clauss S, Weckbach LT, Brunner S. Molecular mechanisms of cardiac remodeling and regeneration in physical exercise. Cells. 2019;8:1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Morikawa Y, Heallen T, Leach J, Xiao Y, Martin JF. Dystrophin‐glycoprotein complex sequesters Yap to inhibit cardiomyocyte proliferation. Nature. 2017;547:227–231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Wang Z, Cui M, Shah AM, Ye W, Tan W, Min YL, Botten GA, Shelton JM, Liu N, Bassel‐Duby R, et al. Mechanistic basis of neonatal heart regeneration revealed by transcriptome and histone modification profiling. Proc Natl Acad Sci USA. 2019;116:18455–18465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Fan Q, Mao H, Angelini A, Coarfa C, Robertson MJ, Lagor WR, Wehrens XHT, Martin JF, Pi X, Xie L. Depletion of endothelial prolyl hydroxylase domain protein 2 and 3 promotes cardiomyocyte proliferation and prevents ventricular failure induced by myocardial infarction. Circulation. 2019;140:440–442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Andersen DC, Jensen CH, Baun C, Hvidsten S, Zebrowski DC, Engel FB, Sheikh SP. Persistent scarring and dilated cardiomyopathy suggest incomplete regeneration of the apex resected neonatal mouse myocardium–a 180 days follow up study. J Mol Cell Cardiol. 2016;90:47–52. [DOI] [PubMed] [Google Scholar]
- 8. Cai W, Tan J, Yan J, Zhang L, Cai X, Wang H, Liu F, Ye M, Cai CL. Limited regeneration potential with minimal epicardial progenitor conversions in the neonatal mouse heart after injury. Cell Rep. 2019;28:190–201.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Quaife‐Ryan GA, Sim CB, Ziemann M, Kaspi A, Rafehi H, Ramialison M, El‐Osta A, Hudson JE, Porrello ER. Multicellular transcriptional analysis of mammalian heart regeneration. Circulation. 2017;136:1123–1139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Bryant DM, O'Meara CC, Ho NN, Gannon J, Cai L, Lee RT. A systematic analysis of neonatal mouse heart regeneration after apical resection. J Mol Cell Cardiol. 2015;79:315–318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Haubner BJ, Adamowicz‐Brice M, Khadayate S, Tiefenthaler V, Metzler B, Aitman T, Penninger JM. Complete cardiac regeneration in a mouse model of myocardial infarction. Aging (Albany NY). 2012;4:966–977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Hoog TG, Fredrickson SJ, Hsu CW, Senger SM, Dickinson ME, Udan RS. The effects of reduced hemodynamic loading on morphogenesis of the mouse embryonic heart. Dev Biol. 2018;442:127–137. [DOI] [PubMed] [Google Scholar]
- 13. Malek Mohammadi M, Abouissa A, Azizah I, Xie Y, Cordero J, Shirvani A, Gigina A, Engelhardt M, Trogisch FA, Geffers R, et al. Induction of cardiomyocyte proliferation and angiogenesis protects neonatal mice from pressure overload‐associated maladaptation. JCI Insight. 2019;5:e128336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Downing TE, Kim YY. Tetralogy of Fallot: general principles of management. Cardiol Clin. 2015;33:531–541, vii‐viii. [DOI] [PubMed] [Google Scholar]
- 15. Vriz O, Pirisi M, Bossone E, Fadl ElMula FEM, Palatini P, Naeije R. Right ventricular‐pulmonary arterial uncoupling in mild‐to‐moderate systemic hypertension. J Hypertens. 2020;38:228–274. [DOI] [PubMed] [Google Scholar]
- 16. Driessen MM, Hui W, Bijnens BH, Dragulescu A, Mertens L, Meijboom FJ, Friedberg MK. Adverse ventricular‐ventricular interactions in right ventricular pressure load: insights from pediatric pulmonary hypertension versus pulmonary stenosis. Physiol Rep. 2016;4:e12833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Graves CE, Harrison MR, Padilla BE. Minimally invasive fetal surgery. Clin Perinatol. 2017;44:729–751. [DOI] [PubMed] [Google Scholar]
- 18. Spray TL, Mallory GB, Canter CB, Huddleston CB. Pediatric lung transplantation. Indications, techniques, and early results. J Thorac Cardiovasc Surg. 1994;107:990–999; discussion 999–1000. [PubMed] [Google Scholar]
- 19. Reddy S, Zhao M, Hu D‐Q, Fajardo G, Hu S, Ghosh Z, Rajagopalan V, Wu J‐C, Bernstein D. Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. Physiol Genomics. 2011;44:562–575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Hsu DT, Zak V, Mahony L, Sleeper LA, Atz AM, Levine JC, Barker PC, Ravishankar C, McCrindle BW, Williams RV, et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010;122:333–340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Wang S, Ye L, Hong H, Tang C, Li M, Zhang Z, Liu J. A neonatal rat model of increased right ventricular afterload by pulmonary artery banding. J Thorac Cardiovasc Surg. 2017;154:1734–1739. [DOI] [PubMed] [Google Scholar]
- 22. Ye L, Qiu L, Zhang H, Chen H, Jiang C, Hong H, Liu J. Cardiomyocytes in young infants with congenital heart disease: a three‐month window of proliferation. Sci Rep. 2016;6:23188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Polizzotti BD, Ganapathy B, Walsh S, Choudhury S, Ammanamanchi N, Bennett DG, dos Remedios CG, Haubner BJ, Penninger JM, Kühn B. Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window. Sci Transl Med. 2015;7:281ra45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Wang S, Ye L, Li M, Liu J, Jiang C, Hong H, Zhu H, Sun Y. GSK‐3β inhibitor CHIR‐99021 promotes proliferation through upregulating β‐catenin in neonatal atrial human cardiomyocytes. J Cardiovasc Pharmacol. 2016;68:425–432. [DOI] [PubMed] [Google Scholar]
- 25. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331:1078–1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Notari M, Ventura‐Rubio A, Bedford‐Guaus SJ, Jorba I, Mulero L, Navajas D, Martí M, Raya Á. The local microenvironment limits the regenerative potential of the mouse neonatal heart. Sci Adv. 2018;4:eaao5553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Weiss A, Neubauer MC, Yerabolu D, Kojonazarov B, Schlueter BC, Neubert L, Jonigk D, Baal N, Ruppert C, Dorfmuller P, et al. Targeting cyclin‐dependent kinases for the treatment of pulmonary arterial hypertension. Nat Commun. 2019;10:2204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Kurosawa R, Satoh K, Kikuchi N, Kikuchi H, Saigusa D, Al‐Mamun ME, Siddique MAH, Omura J, Satoh T, Sunamura S, et al. Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension. Circ Res. 2019;125:309–327. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.